Search Ontology:
ChEBI
BMS 195614
- Term ID
- CHEBI:132571
- Synonyms
-
- 4-({[5,5-dimethyl-8-(quinolin-3-yl)-5,6-dihydronaphthalen-2-yl]carbonyl}amino)benzoic acid
- 4-[(5,5-dimethyl-8-quinolin-3-yl-6H-naphthalene-2-carbonyl)amino]benzoic acid
- 4-[[[5,6-Dihydro-5,5-dimethyl-8-(3-quinolinyl)-2-naphthalenyl]carbonyl]amino]benzoic acid
- BMS 614
- BMS-195614
- BMS-614
- BMS195614
- BMS614
- CID:445091
- Definition
- A carboxamide resulting from the formal condensation of the carboxy group of 5,5-dimethyl-8-(quinolin-3-yl)-5,6-dihydronaphthalene-2-carboxylic acid with the amino group of p-aminobenzoic acid. It is a neutral retinoic acid receptor (RAR) alpha-selective antagonist (Ki = 2.5 nM). It displays no significant effect on nuclear receptor corepressor (NCoR) binding; moderately decreases SMRT binding to RAR. It antagonizes agonist-induced coactivator (CoA) recruitment.
- References
-
- CAS:253310-42-8
- PMID:11212271
- PMID:17906643
- PMID:9312028
- Reaxys:24414151
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from BMS 195614
Phenotype where environments contain BMS 195614
Phenotype modified by environments containing BMS 195614
Human Disease Model